PharmaOne Appoints Advisory Board for MEA Healthcare Growth
Pharma One Medical Store LLC, the regional healthcare commercialisation company focused on innovative therapeutics,
Singapore, 4th Jul 2026 – Pharma One Medical Store LLC, the regional healthcare commercialisation company focused on innovative therapeutics, diagnostics and healthcare solutions across the Middle East and Africa, has appointed its Advisory Board to support the next phase of its growth. Selected through the Veblen Director Programme, the five advisors bring expertise across life sciences, commercial strategy, governance, operations, automation and process excellence. Their appointment will support PharmaOne as it strengthens its position as a one-stop regional partner for pharmaceutical, biotechnology and healthcare companies seeking access to the rapidly growing MEA market.
“PharmaOne was established to help innovative healthcare companies navigate the complexity of the MEA region with the right commercial, regulatory and strategic support,” said Mohamed Nabil, Founder of Pharma One Medical Store LLC. “This Advisory Board brings valuable experience across healthcare, growth, governance and operational delivery, and I am delighted to welcome them as we continue expanding our reach and building long-term value for partners across the region.”
Appointed Advisory Board Members
Ashley Bird – Chair of the Board, a life sciences consultant, board member and Non-Executive Director with more than 25 years of experience across Life Sciences, Diagnostics and MedTech. She brings expertise in commercial strategy, execution, culture and leadership alignment, helping businesses cut through complexity and deliver sustainable growth.
“PharmaOne is addressing a significant opportunity in the regional healthcare market with a clear commercial purpose and strong sector relevance,” said Ashley Bird, Chair of the Board at PharmaOne. “I look forward to supporting the business as it sharpens execution, strengthens partnerships and builds the next phase of growth.”
Emmerentia Myburgh (Rentia) – Board Advisor, a healthcare marketing leader with more than two decades of experience in competitive strategy, direct-to-consumer marketing and patient engagement. She brings expertise in marketing management, brand positioning and aligning healthcare offerings with evolving market needs.
“I am excited to support PharmaOne’s strategic growth and innovation as it continues to strengthen its role in the healthcare ecosystem,” said Emmerentia Myburgh (Rentia), Board Advisor at PharmaOne.
Stephen Walker – Board Advisor, a business advisor with experience founding, scaling, acquiring and advising owner-managed businesses across engineering, property and services. He brings expertise in strategic direction, operational clarity, governance, management accountability and building scalable structures that support long-term value creation.
“PharmaOne has a strong platform and a clear market need. I look forward to supporting the team as it builds greater structure, scale and optionality for the next stage of growth,” said Stephen Walker, Board Advisor at PharmaOne.
Srinivasa Ruttala – Board Advisor, a manufacturing and automation leader with more than 20 years of experience spanning pharmaceuticals, chemicals and industrial operations. He brings expertise in project management, GMP compliance, digital transformation, AI and board-level technical governance across complex manufacturing environments.
“PharmaOne is well placed at the intersection of healthcare innovation, operational execution and regional growth,” said Srinivasa Ruttala, Board Advisor at PharmaOne. “I am pleased to support the business as it builds stronger systems, scalable capability and long-term strategic value.”
Elyas Al Dawood – Board Advisor, an engineering leader with 15 years of experience in project execution, process design and plant operations across the Middle East and the United States. He brings expertise in multi-discipline engineering leadership, process safety, design review and operational troubleshooting across complex industrial environments.
“I am pleased to support PharmaOne as it strengthens its operational foundations and expands its contribution to innovative healthcare access across the region,” said Elyas Al Dawood, Board Advisor at PharmaOne.
The appointment of the Advisory Board marks an important step in PharmaOne’s development as the company continues to expand its regional network, deepen its commercial capabilities and support healthcare innovators seeking effective access to the MEA market.
About Pharma One Medical Store LLC
PharmaOne was established in 2022 by partners with more than 60 years of combined experience in the pharmaceutical and healthcare fields across the Middle East and Africa. The company provides a one-stop regional solution to pharmaceuticals, biologicals, genomics and other innovative healthcare businesses, with a focus on commercialising therapeutics and diagnostics that address unmet medical needs in emerging MEA markets. Its regional expertise and strong business network position PharmaOne as a partner of choice for healthcare companies seeking growth in the region.
Learn more at: www.pharmaonetrading.com
About the Veblen Director Programme
The Veblen Director Programme empowers executives and professionals with the skills and knowledge to excel in board and advisory roles. Through training, education, and a global network of skilled board members, Veblen supports organisations in navigating complex challenges, driving sustainable growth, and building impactful leadership teams.
Learn more at: https://www.veblendirectors.com
For media enquiries, please contact: franzi@financialmedia.group
Company Details
Organization: Financial Media Group Ltd
Contact Person: Franziska Grobler
Website: https://www.financialmedia.group/
Email: Send Email
Contact Number: +6584555350
Address: 51 Goldhill Plaza
Address 2: #07-10/11
City: Singapore
State: — None —
Country: Singapore
Release Id: 04072646796